POST-FEDERAL BUDGET RESPONSE: AUSTRALIAN THYROID FOUNDATION 1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage
At the Post Budget Breakfast hosted by AIPS and Medicines Australia, the Honourable Mark Butler MP, Minister for Health and Aged Care spoke about the health priorities of the Federal Budget 2024-25.
As with all Federal Budgets, there is a submission process to lodge requests by January of each year. For the Federal Budget this year, there were 788 submissions lodged, one of which was by the Australian Thyroid Foundation (ATF).
The ATF is a national not-for-profit organisation with charity status aimed at patients and the healthcare community. The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community.
Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.
The 3 requests for funding were for,
1. Education tool kit for health care professionals, to use during patient presentations
2. Broad media campaign aimed at young families moving away from standard dietary choices and awareness about the importance of iodine and thyroid health
3. Dietary book for senior Australians with an iodine slant to improve health outcomes, with healthy living choices.
According to the Australia Thyroid Foundation, over 1 million Australians are living with an undiagnosed thyroid disorder. These disorders can affect children, pregnant women, families and the elderly.
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
-
Sovereign capability uplifted
Skilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce.
Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies.
-
Keeping elderly out of hospital
Pioneer in health care, Geriatrician Professor Susan Kurrle, Curran Professor in Health Care of Older People at the Faculty of Medicine and Health, University of Sydney AO spoke after receiving the Australian Healthcare and Hospitals Association 2022 Sidney Sax medal award.
The Sidney Sax medal is awarded for outstanding contributions to the development and improvement of Australia’s healthcare system.
